UK MIDDAY BRIEFING: Glaxo In Collaboration On Cancer Drugs
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> has signed a collaboration and licensing agreement with UK-based biotechnology company Adaptimmune Ltd for its cancer programme, a move that comes just weeks after it agreed to sell its own cancer drug business to Novartis as part of a Read More